about
ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylationMice deficient for the wild-type p53-induced phosphatase gene (Wip1) exhibit defects in reproductive organs, immune function, and cell cycle controlWip1 phosphatase: between p53 and MAPK kinases pathwaysAmplification of PPM1D in human tumors abrogates p53 tumor-suppressor activitySubstrate specificity of the human protein phosphatase 2Cdelta, Wip1Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapyPhosphatase WIP1 regulates adult neurogenesis and WNT signaling during agingWip1 promotes RUNX2-dependent apoptosis in p53-negative tumors and protects normal tissues during treatment with anticancer agentsWip1 sensitizes p53-negative tumors to apoptosis by regulating the Bax/Bcl-xL ratioRegulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase.Role of Gadd45a in Wip1-dependent regulation of intestinal tumorigenesisWip1 phosphatase positively modulates dendritic spine morphology and memory processes through the p38MAPK signaling pathway.Induction of PPM1D following DNA-damaging treatments through a conserved p53 response element coincides with a shift in the use of transcription initiation sites.Inhibition of HSP70: a challenging anti-cancer strategy.HSP110 promotes colorectal cancer growth through STAT3 activation.Glutathione prevents preterm parturition and fetal death by targeting macrophage-induced reactive oxygen species production in the myometrium.DNA damage-induced phosphatase Wip1 in regulation of hematopoiesis, immune system and inflammation.Chemical inhibition of Wip1 phosphatase contributes to suppression of tumorigenesis.Peptides and aptamers targeting HSP70: a novel approach for anticancer chemotherapy.Wip1 regulates the generation of new neural cells in the adult olfactory bulb through p53-dependent cell cycle control.Wip1 phosphatase regulates p53-dependent apoptosis of stem cells and tumorigenesis in the mouse intestine.The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development.The role of the MKK6/p38 MAPK pathway in Wip1-dependent regulation of ErbB2-driven mammary gland tumorigenesis.Wip1 phosphatase-deficient mice exhibit defective T cell maturation due to sustained p53 activation.Erratum: The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease developmentp38MAPK Controls Expression of Multiple Cell Cycle Inhibitors and Islet Proliferation with Advancing AgeWip1 inhibition leads to severe pro-inflammatory phenotype in skin in response to chemical irritationTumor Susceptibility and Apoptosis Defect in a Mouse Strain Expressing a Human p53 TransgeneWip1 Phosphatase Modulates ATM-Dependent Signaling PathwaysHeat shock proteins in cardiosurgery patientsHSP110 translocates to the nucleus upon genotoxic chemotherapy and promotes DNA repair in colorectal cancer cells[A method for determining the constitutive and inducible forms of a heat-shock protein of 70 kDa in the human myocardium and lymphocytes][Autoinduced myocardial tolerance to ischemia: the role of stress proteins in the mechanisms of its occurrence][Heat shock proteins: new prospects of myocardial cytoprotection][Role of heat-shock proteins in cardioprotection of patients operated on for ischemic heart disease]TRIM33 prevents pulmonary fibrosis by impairing TGF-β1 signalingNovel isatin-derived molecules activate p53 via interference with Mdm2 to promote apoptosisROLE OF Wip1-p53 AXIS IN RESPONSE OF MURINE CELLS TO TREATMENT WITH SODIUM BUTYRATE AND MEK/ERK SIGNALLING PATHWAY INHIBITOREMT: A mechanism for escape from EGFR-targeted therapy in lung cancer
P50
Q24529998-16FF7709-FB24-45F8-8C0C-40A109A6AD1DQ24537538-8CEFDDD0-3AC4-4702-A66F-332B413FC3C0Q26863035-B2CD938D-3DAF-4BB7-9E34-896966A34CD5Q28218469-3E1A77CD-B811-4178-A6AC-A4AFF9351AF0Q28243258-B0DC038A-3E26-4A88-8159-4E4A82873EEEQ28833606-6632D7AC-BA44-4742-BF44-58A1EBA9F9C1Q33808257-2BE051DD-3E6D-4648-BDF0-8CBB1E71ED55Q35673760-3A5F950B-96FE-4223-A29E-9512A8AC833EQ35984061-34F46E83-D4A2-45A0-AE98-1D5A136BC9B8Q36228219-B302A85B-3877-4E31-9813-DDC508C329AEQ36311141-07F4099C-8608-486E-A12D-DAE4AD2753C6Q36338674-ADB92FFD-A77B-41DA-8180-C25AE14F3E44Q37014644-983E0B66-53BB-46D5-A431-511AE179849DQ38023055-B0BEE4FF-D93E-472A-BFF0-32E9CB1EA7E0Q38732570-5ECF2B0D-9413-438F-BA75-D8A1D6FC9D52Q38901576-67C85894-6F09-49FD-ABA2-5D9782A3C0DFQ39247204-1918FD5F-F8CD-46F8-9143-60A6839C6B1CQ40356588-55EC8739-F23B-40AC-809F-6F18C21668FFQ45719919-997B8C88-AA0B-4C83-B336-292D12AC113CQ47673151-48AC7C26-1622-4FD4-9131-4F46A2D15667Q53322778-8563299A-5483-46DC-9332-C0A68FDF8036Q53347165-00ECC126-D9E6-4E36-9460-0FD3289E7A27Q53595739-1C6A98A5-6D4A-495C-956A-B294C5EE7873Q53629038-054FE03F-659C-48DA-A502-E4A257FFB42EQ57219428-DA0CC34F-8363-41EF-B9C2-233CFBE93CAAQ57276990-0C920E7E-4B1E-44AC-A02D-D0376F496AD3Q61849105-A8D52D6C-0716-492A-A154-C6CDA5C374E4Q61849110-E3C3D8B3-1827-4E7B-9936-E8C1E2F14EB7Q61849111-163432E1-B317-4933-8C53-A5CE97A057D3Q61849112-DC04D074-D758-4D75-8944-13E4064A7234Q64388565-E10085DA-AE26-498E-8809-BC42EEE19C07Q73950265-2AB0CD0F-4A30-421F-A04F-25CFC6EB7E3EQ77327942-80ADC6C7-17AD-4A06-A5D7-555552481F67Q78194269-D43E23A5-583D-41B2-831C-7D8DF0F5FB58Q78244314-0B8CA221-7E29-4BF9-946D-469A3F0C2536Q90407576-95F9BEDA-D369-46D9-82AA-AD513D7AD5FAQ90955508-6DA1CDF5-E682-463C-9532-5258CA2BCD3FQ91313457-F5AE24BD-0B1B-4ECE-951B-078B81170E13Q93007764-1054BCD8-87F5-4E60-BB81-C50560BCDB18
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Oleg N. Demidov
@ast
Oleg N. Demidov
@en
Oleg N. Demidov
@es
Oleg N. Demidov
@nl
Oleg N. Demidov
@sl
type
label
Oleg N. Demidov
@ast
Oleg N. Demidov
@en
Oleg N. Demidov
@es
Oleg N. Demidov
@nl
Oleg N. Demidov
@sl
prefLabel
Oleg N. Demidov
@ast
Oleg N. Demidov
@en
Oleg N. Demidov
@es
Oleg N. Demidov
@nl
Oleg N. Demidov
@sl
P1053
U-2050-2017
P106
P1153
8045768500
P21
P31
P3829
P496
0000-0003-4323-7174